Literature DB >> 31704430

Sex differences in the relationship between anxiety sensitivity and opioid misuse among adults with chronic pain.

Andrew H Rogers1, Kara Manning1, Lorra Garey1, Tanya Smit1, Michael J Zvolensky2.   

Abstract

The opioid epidemic is a significant public health concern linked to chronic pain. Despite efforts to change opioid prescribing practices for chronic pain, opioid-involved overdoses remain at an all-time high. Research focused on identifying individual difference factors for problematic opioid misuse in the context of chronic pain have identified certain psychological variables that may confer heightened risk for opioid-related problems. Anxiety sensitivity, or fear of anxiety-related physical sensations, has been linked to opioid-related problems among adults with chronic pain. Yet, it is possible that these relations may not be distributed equally in society, and sex differences may be one avenue by which these relations differ. Therefore, the current study examined the moderating role of sex on the relation between anxiety sensitivity, current opioid misuse, and severity of opioid dependence among 428 adults (74.9% female, Mage = 38.28 years, SD = 11.06) with chronic pain. Results indicated that the relation between anxiety sensitivity and current opioid misuse (ΔR2 = 0.005, B = 0.12, SE = 0.06, p = 0.04), and opioid dependence (ΔR2 = 0.01, B = 0.04, SE = 0.02, p = 0.007) was stronger for males compared to females. These results suggest that anxiety sensitivity may be associated with opioid-related problems to a greater extent for males than females. Continued research is needed to examine how these sex differences may impact clinical treatment for opioid-related problems.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety sensitivity; Chronic pain; Opioids; Sex differences

Mesh:

Substances:

Year:  2019        PMID: 31704430     DOI: 10.1016/j.addbeh.2019.106156

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

1.  Novel TRPV1 Modulators with Reduced Pungency Induce Analgesic Effects in Mice.

Authors:  Anny Treat; Vianie Henri; Junke Liu; Joyce Shen; Mauricio Gil-Silva; Alejandro Morales; Avaneesh Rade; Kevin Joseph Tidgewell; Benedict Kolber; Young Shen
Journal:  ACS Omega       Date:  2022-01-10

2.  Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesia.

Authors:  Amanda Lillywhite; Stephen G Woodhams; Sara V Gonçalves; David J G Watson; Li Li; James J Burston; Peter R W Gowler; Meritxell Canals; David A Walsh; Gareth J Hathway; Victoria Chapman
Journal:  Pain Rep       Date:  2022-02-03

3.  Prevalence of Long-Term Opioid Therapy in a Chronic Non-Cancer Pain Population Attending a University-Based Tertiary Pain Clinic in Sweden: A Cross-Sectional Study.

Authors:  Henrik Grelz; Marcelo Rivano Fischer; Mirnabi Priouzifard; Patrik Midlöv; Åsa Ringqvist
Journal:  J Rehabil Med       Date:  2022-04-29       Impact factor: 3.959

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.